Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Don't Want to Miss
FDA approves new Alzheimer's PET imaging agent from Lantheus
Friday, August 14, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News You Don't Want to Miss

FDA approves new Alzheimer’s PET imaging agent from Lantheus

Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease. 

READ MORE >
brain alzheimers pet scan drug CT dementia
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new Alzheimer’s PET imaging agent from Lantheus

Share on Twitter Share on Facebook Share on Linkedin
brain alzheimers pet scan drug CT dementia
Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease. 
READ MORE >

In Case You Missed It

Curium inks definitive deal to acquire radiopharma rival Lantheus for up to $8B

“This combination unlocks an opportunity that neither company could achieve alone, as it positions us to reach significantly more patients and clinicians globally,” Curium CEO Renaud Dehareng said Aug. 3. 

READ MORE >
curium
Share on Twitter Share on Facebook Share on Linkedin

Curium inks definitive deal to acquire radiopharma rival Lantheus for up to $8B

Share on Twitter Share on Facebook Share on Linkedin
curium
“This combination unlocks an opportunity that neither company could achieve alone, as it positions us to reach significantly more patients and clinicians globally,” Curium CEO Renaud Dehareng said Aug. 3. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Senate bill would slash radiology spending | MRI links ultraprocessed foods to brain injury | New imaging clinic chain launches
How departments are reducing wait times | Program increases exposure to radiology careers | Gaps in radiation safety knowledge
A warning about BI-RADS | 3-step buyer's guide for radiology AI | IR procedure reduces steroid reliance for KOA | Rad turnover
Radiologists worry of ripple effect after false claims | AI matches rads at prostate cancer detection | Rad Partners scores win
GE HealthCare acquiring radiopharma firm | RP seeks to expand teleradiology services | Telix and ITM merge in $1.65B deal | More
Siemens Healthineers ends general ultrasound sales | More liver cancer patients turning to IR treatments | Anxiety on MRI
Imaging systems recalled after 4 deaths | Radiology trainees balk at strict in-person work models | Bayer sells Blackford
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup